PTGER3 Blocking Peptide

General Information

Product

PTGER3 Peptide

Description

Antigenic Blocking Peptide Protaglandin Receptor EP3D

Verified Applications

Immunocompetition, Immunodepletion

Peptide Description

Accession #

NCBI:  XP_009209142.1

Physical Properties

Quantity

250 µg

Volume

100 µl

Form

Antigenic Blocking Peptide

Storage

-20⁰C for long term storage

Application Protocol

Competition/Depletion assay

Refer to competition assay protocol

Protein

Uniprot #

UPI0004F2137B

Overview

Receptor for prostaglandin E2 (PGE2); the EP3 receptor may be involved in inhibition of gastric acid secretion, modulation of neurotransmitter release in central and peripheral neurons, inhibition of sodium and water reabsorption in kidney tubulus and contraction in uterine smooth muscle. The activity of this receptor can couple to both the inhibition of adenylate cyclase mediated by G-I proteins, and to an elevation of intracellular calcium. The various isoforms have identical ligand binding properties but can interact with different second messenger systems (By similarity).

Molecular Function

Prostaglandin E receptor activity, G-protein coupled receptor

Subcellular Location

Cell membrane; Multi-pass membrane

Expression

Expressed in small intestine, heart, pancreas, gastric fundic mucosa, mammary artery and pulmonary vessels.

Structure

Belongs to the G-protein coupled receptor 1 family.

Alternative Nomenclature

EP 3 antibody

EP3 I antibody

EP3 II antibody

EP3 III antibody

EP3 IV antibody

Ep3 prostanoid receptor antibody

Ep3 receptor antibody

EP3 subtype antibody

EP3e antibody

MGC141828 antibody

MGC141829 antibody

PGE receptor EP3 subtype antibody

PGE2 R antibody

Pgerep3 antibody

Prostaglandin E receptor EP3 subtype 3 isoform antibody

Prostanoid EP3 receptor antibody

PTGER 3 antibody

Rep3 antibody

rEP3a antibody

rEP3b antibody